There is a newer version of the record available.

Published October 27, 2020 | Version v1
Preprint Open

Detection of toxin-like peptides in plasma and urine samples from COVID-19 patients

  • 1. Craniomed group srl, Montemiletto, Italy
  • 2. European Commission, Joint Research Centre (JRC), Ispra, Italy
  • 3. ISB Ion Source & Biotechnologies srl, Bresso, Italy
  • 4. Department of Medicine and Surgery University of Salerno, Baronissi, Italy
  • 5. European Commission, Joint Research Centre (JRC), Geel, Belgium



The frequent association between COVID-19 disease and different extrapulmonary clinical manifestations in symptomatic patients was reported recently.

The data reported here suggest an association between COVID-19 disease and the release in the body of (oligo-)peptides almost identical to toxic components of venoms from animals. The presence of these peptides opens new scenarios on the aetiology of the COVID-19 clinical symptoms observed up to now, including neurological manifestations.


DECLARATION The scientific output expressed does not imply a policy position of the European Commission. Neither the European Commission nor any person acting on behalf of the Commission is responsible for the use that might be made of this publication.



Files (29.9 MB)

Name Size Download all
986.0 kB Preview Download
28.9 MB Preview Download